ArticleCore evidence2012

Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia.

Klaus G ParhoferPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.